Aslihan Ekim Kocabey

Dr. Aslihan Ekim Kocabey

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SKSamet Kocabey
Samet Kocabey
AKAslihan Ekim Kocabey
Aslihan Ekim Kocabey
Roger SchneiterRoger Schneiter
Roger Schneiter
Curzio RueggCurzio Ruegg
Curzio Ruegg
DNA nanotechnology offers to build nanoscale structures with defined chemistries to precisely position biomolecules or drugs for selective cell targeting and drug delivery. Owing to the negatively charged nature of DNA, for delivery purposes, DNA is frequently conjugated with hydrophobic moieties, positively charged polymers/peptides and cell surface receptor-recognizing molecules or antibodies. Here, we designed and assembled cholesterol-modified DNA nanotubes to interact with cancer cells and conjugated them with cytochrome c to induce cancer cell apoptosis. By flow cytometry and confocal microscopy, we observed that DNA nanotubes efficiently bound to the plasma membrane as a function of the number of conjugated cholesterol moieties. The complex was taken up by the cells and localized to the endosomal compartment. Cholesterol-modified DNA nanotubes, but not unmodified ones, increased membrane permeability, caspase activation and cell death. Irreversible inhibition of caspase activity with a caspase inhibitor, however, only partially prevented cell death. Cytochrome c-conjugated DNA nanotubes were also efficiently taken up but did not increase the rate of cell death. These results demonstrate that cholesterol-modified DNA nanotubes induce cancer cell death associated with increased cell membrane permeability and are only partially dependent on caspase activity, consistent with a combined form of apoptotic and necrotic cell death. DNA nanotubes may be further developed as primary cytotoxic agents, or drug delivery vehicles, through cholesterol-mediated cellular membrane interactions and uptake.

19 January 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
OAOla El Atab
Ola El Atab
AKAslihan Ekim Kocabey
Aslihan Ekim Kocabey
OAOluwatoyin Asojo
Oluwatoyin Asojo
Roger SchneiterRoger Schneiter
Roger Schneiter
Members of the CAP protein superfamily are present in all kingdoms of life and have been implicated in many different processes, including pathogen defense, immune evasion, sperm maturation, and cancer progression. Most CAP proteins are secreted glycoproteins and share a unique conserved αβα sandwich fold. The precise mode of action of this class of proteins, however, has remained elusive. Saccharomyces cerevisiae has three CAP family members, termed pathogen related in yeast (Pry). We have previously shown that Pry1 and Pry2 export sterols in vivo and that they bind sterols in vitro. This sterol binding and export function of yeast Pry proteins is conserved in the mammalian CRISP proteins and other CAP superfamily members. CRISP3 is an abundant protein of the human seminal plasma and interacts with prostate secretory protein of 94 amino acids (PSP94), another major protein component in the seminal plasma. Here we examine whether the interaction between CRISP proteins and PSP94 affects the sterol binding function of CAP family members. We show that coexpression of PSP94 with CAP proteins in yeast abolished their sterol export function and the interaction between PSP94 and CAP proteins inhibits sterol binding in vitro. In addition, mutations that affect the formation of the PSP94–CRISP2 heteromeric complex restore sterol binding. Of interest, we found the interaction of PSP94 with CRISP2 is sensitive to high calcium concentrations. The observation that PSP94 modulates the sterol binding function of CRISP2 in a calcium-dependent manner has potential implications for the role of PSP94 and CRISP2 in prostate physiology and progression of prostate cancer.

4 August 2021
Verified
Dataset
Open access
SKSamet Kocabey
Samet Kocabey
AKAslihan Ekim Kocabey
Aslihan Ekim Kocabey
RSRoger Schneiter
Roger Schneiter
CRCurzio Ruegg
Curzio Ruegg
This dataset contains the raw data that were used for the publication entitled, "Membrane-Interacting DNA Nanotubes Induce Cancer Cell Death" published in Nanomaterials on 4 August 2021. DNA nanotechnology offers to build nanoscale structures with defined chemistries to precisely position biomolecules or drugs for selective cell targeting and drug delivery. Owing to the negatively charged nature of DNA, for delivery purposes DNA is frequently conjugated with hydrophobic moieties, positively charged polymers/peptides, cell surface receptor recognizing molecules or antibodies. Here, we designed and assembled cholesterol-modified DNA nanotubes to interact with cancer cells and conjugated them with cytochrome c to induce cancer cell apoptosis. By flow cytometry and confocal microscopy, we observed that DNA nanotubes efficiently bound to the plasma membrane as a function of the number of conjugated cholesterol moieties. The complex was taken up by the cells and localized to the endosomal compartment. Cholesterol-modified DNA nanotubes, but not unmodified ones, induced increased membrane permeability, caspase activation and cell death. Irreversible inhibition of caspase activity, with Z-VAD-FMK, however, only partially prevented cell death. Cytochrome c conjugated DNA nanotubes were also efficiently taken up but did not increased the rate of cell death. These results demonstrate that cholesterol-modified DNA nanotubes induce cancer cell death associated with increased cell membrane permeability and only partially dependent on caspase activity, consistent with a combined form of apoptotic and necrotic cell death. DNA nanotubes may be further developed as primary cytotoxic agents, or drug delivery vehicles, through cholesterol mediated cellular membrane interactions and uptake.

4 August 2021
Verified
Dataset
Open access
SKSamet Kocabey
Samet Kocabey
AKAslihan Ekim Kocabey
Aslihan Ekim Kocabey
RSRoger Schneiter
Roger Schneiter
CRCurzio Ruegg
Curzio Ruegg
This dataset contains the raw data that were used for the publication entitled, "Membrane-Interacting DNA Nanotubes Induce Cancer Cell Death" published in Nanomaterials on 4 August 2021. DNA nanotechnology offers to build nanoscale structures with defined chemistries to precisely position biomolecules or drugs for selective cell targeting and drug delivery. Owing to the negatively charged nature of DNA, for delivery purposes DNA is frequently conjugated with hydrophobic moieties, positively charged polymers/peptides, cell surface receptor recognizing molecules or antibodies. Here, we designed and assembled cholesterol-modified DNA nanotubes to interact with cancer cells and conjugated them with cytochrome c to induce cancer cell apoptosis. By flow cytometry and confocal microscopy, we observed that DNA nanotubes efficiently bound to the plasma membrane as a function of the number of conjugated cholesterol moieties. The complex was taken up by the cells and localized to the endosomal compartment. Cholesterol-modified DNA nanotubes, but not unmodified ones, induced increased membrane permeability, caspase activation and cell death. Irreversible inhibition of caspase activity, with Z-VAD-FMK, however, only partially prevented cell death. Cytochrome c conjugated DNA nanotubes were also efficiently taken up but did not increased the rate of cell death. These results demonstrate that cholesterol-modified DNA nanotubes induce cancer cell death associated with increased cell membrane permeability and only partially dependent on caspase activity, consistent with a combined form of apoptotic and necrotic cell death. DNA nanotubes may be further developed as primary cytotoxic agents, or drug delivery vehicles, through cholesterol mediated cellular membrane interactions and uptake.